Bhatt Elizabeth 4
4 · Septerna, Inc. · Filed Apr 17, 2026
Research Summary
AI-generated summary of this filing
Septerna (SEPN) President Elizabeth Bhatt Sells Shares, Exercises Options
What Happened
- Elizabeth Bhatt, President and COO of Septerna, exercised options to acquire 4,000 shares at $6.81 per share (total exercise cost $27,240) and the filing also reports a derivative disposition of 4,000 shares at $0.00 in connection with the exercise. On the same date (2026-04-15) she sold 4,000 shares in the open market in multiple transactions for aggregate proceeds of approximately $97,344. The sales were effected pursuant to a Rule 10b5-1 sales plan.
Key Details
- Transaction date: April 15, 2026.
- Option exercise (M): 4,000 shares acquired @ $6.81 — $27,240 total.
- Derivative disposition (M): 4,000 shares reported disposed @ $0.00 (filing does not explain the $0.00 disposition).
- Open-market sales (S): 2,573 shares @ weighted avg $23.76 (range $23.33–$24.22), 1,101 shares @ weighted avg $25.24 (range $24.79–$25.75), 326 shares @ weighted avg $25.86 (range $25.81–$25.91). Total cash proceeds from sales ≈ $97,344.
- Shares owned after transaction: not specified in the Form 4 provided.
- Footnotes: sales were made under a Rule 10b5-1 plan adopted Oct 20, 2025 (F1). F2–F4 note weighted-average prices and price ranges for the multiple sale lots. F5 describes vesting terms for the underlying option (1/48th monthly starting Oct 28, 2024, contingent on IPO and continued service).
- Filing timeliness: Form filed Apr 17, 2026 covering Apr 15 transactions — no late filing indicated in the document.
Context
- The filing shows an option exercise plus contemporaneous sales. The separate derivative disposition at $0.00 may reflect a non-cash settlement mechanism (e.g., share surrender or withholding), but the Form 4 itself does not provide an explicit explanation. Sales were executed under a pre-established 10b5-1 plan, which is a routine method insiders use to sell shares according to a predetermined schedule.
Insider Transaction Report
Form 4
Septerna, Inc.SEPN
Bhatt Elizabeth
President and COO
Transactions
- Exercise/Conversion
Common Stock
2026-04-15$6.81/sh+4,000$27,240→ 178,209 total - Sale
Common Stock
[F1][F2]2026-04-15$23.76/sh−2,573$61,124→ 175,636 total - Sale
Common Stock
[F1][F3]2026-04-15$25.24/sh−1,101$27,789→ 174,535 total - Sale
Common Stock
[F1][F4]2026-04-15$25.86/sh−326$8,431→ 174,209 total - Exercise/Conversion
Stock Option (Right to Buy)
[F5]2026-04-15−4,000→ 84,911 totalExercise: $6.81Exp: 2034-09-22→ Common Stock (4,000 underlying)
Footnotes (5)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on October 20, 2025.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.33 to $24.22. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.79 to $25.75. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.81 to $25.91. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F5]1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of October 28, 2024, contingent upon the consummation of the Issuer's initial public offering, and subject to the Reporting Person's continuous service to the Issuer on each such date.
Signature
/s/ Mark A. Wilson, Attorney-in-Fact|2026-04-17